The problem of urogenital candidiasis in women in modern world
Zarochentseva N.V., Belaya Y.M.

Moscow Regional Research Institute of Obstetrics and Gynecology, Moscow

Vulvovaginal candidiasis takes the second place among all vaginal infections and is one of the most common reasons for the visit to gynecologist. Growth of C. albicans and non-albicans resistance to the majority of available drugs conditions the necessity of new efficient medicines search. Therefore, almost one out of ten women with the first episode of acute vulvovaginal candidiasis is at risk of process chronization. 
The article reviews contemporary literature on urogenital candidiasis, diagnostic methods and treatment principles. Information about antifungal drug sertaconazole (Zalain), experience about its clinical usage in obstetrics and gynecology in cases of acute and recurrent process are presented. Comparative analysis with other antimycotics used in gynecological practice is given. On the basis of available Russian scientific trials, high efficacy and compliance for sertaconazole in treatment of acute and chronic vulvovaginal candidiasis are proven, as well as the absence of lactic acid bacteria inhibition, thus avoiding vaginal microbiota dysfunction and significantly reducing the risk of new exacerbations.

Key words: vulvovaginal candidiasis, candidiasis prevalence, diagnosis and treatment methods, pregnancy and candidiasis, sertaconazole.

For citation: Zarochentseva N.V., Belaya Y.M. The problem of urogenital candidiasis in women in modern world // RMJ. 2016. № 15. P. 976–981.